Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

192 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Passive Alzheimer's immunotherapy: A promising or uncertain option?
Høilund-Carlsen PF, Revheim ME, Costa T, Alavi A, Kepp KP, Sensi SL, Perry G, Robakis NK, Barrio JR, Vissel B. Høilund-Carlsen PF, et al. Among authors: sensi sl. Ageing Res Rev. 2023 Sep;90:101996. doi: 10.1016/j.arr.2023.101996. Epub 2023 Jul 5. Ageing Res Rev. 2023. PMID: 37414156 Review.
The Anti-Amyloid Monoclonal Antibody Lecanemab: 16 Cautionary Notes.
Kepp KP, Sensi SL, Johnsen KB, Barrio JR, Høilund-Carlsen PF, Neve RL, Alavi A, Herrup K, Perry G, Robakis NK, Vissel B, Espay AJ. Kepp KP, et al. Among authors: sensi sl. J Alzheimers Dis. 2023;94(2):497-507. doi: 10.3233/JAD-230099. J Alzheimers Dis. 2023. PMID: 37334596
Once upon a time, the Amyloid Cascade Hypothesis.
Granzotto A, Sensi SL. Granzotto A, et al. Among authors: sensi sl. Ageing Res Rev. 2024 Jan;93:102161. doi: 10.1016/j.arr.2023.102161. Epub 2023 Dec 6. Ageing Res Rev. 2024. PMID: 38065226 Free article. Review.
Revision of Alzheimer's diagnostic criteria or relocation of the Potemkin village.
Høilund-Carlsen PF, Alavi A, Barrio JR, Castellani RJ, Costa T, Herrup K, Kepp KP, Neve RL, Perry G, Revheim ME, Robakis NK, Sensi SL, Vissel B. Høilund-Carlsen PF, et al. Among authors: sensi sl. Ageing Res Rev. 2024 Jan;93:102173. doi: 10.1016/j.arr.2023.102173. Epub 2023 Dec 15. Ageing Res Rev. 2024. PMID: 38104639 Free article. Review.
Comparison of Machine Learning-based Approaches to Predict the Conversion to Alzheimer's Disease from Mild Cognitive Impairment.
Franciotti R, Nardini D, Russo M, Onofrj M, Sensi SL; Alzheimer's Disease Neuroimaging Initiative; Alzheimer's Disease Metabolomics Consortium ADMC. Franciotti R, et al. Among authors: sensi sl. Neuroscience. 2023 Mar 15;514:143-152. doi: 10.1016/j.neuroscience.2023.01.029. Epub 2023 Feb 2. Neuroscience. 2023. PMID: 36736612 Free article.
Atrophy of specific amygdala subfields in subjects converting to mild cognitive impairment.
Padulo C, Sestieri C, Punzi M, Picerni E, Chiacchiaretta P, Tullo MG, Granzotto A, Baldassarre A, Onofrj M, Ferretti A, Delli Pizzi S, Sensi SL; Alzheimer's Disease Neuroimaging Iniziative. Padulo C, et al. Among authors: sensi sl. Alzheimers Dement (N Y). 2023 Dec 3;9(4):e12436. doi: 10.1002/trc2.12436. eCollection 2023 Oct-Dec. Alzheimers Dement (N Y). 2023. PMID: 38053753 Free PMC article.
Diagnosis and treatment of late-onset myoclonic epilepsy in Down syndrome (LOMEDS): A systematic review with individual patients' data analysis.
Corniello C, Dono F, Evangelista G, Consoli S, De Angelis S, Cipollone S, Liviello D, Polito G, Melchiorre S, Russo M, Granzotto A, Anzellotti F, Onofrj M, Thomas A, Sensi SL. Corniello C, et al. Among authors: sensi sl. Seizure. 2023 Jul;109:62-67. doi: 10.1016/j.seizure.2023.05.017. Epub 2023 May 21. Seizure. 2023. PMID: 37267668 Free article. Review.
192 results